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In the laboratory attached to the James Pringle House Clinic of The Middlesex Hospital, two screening tests are currently used to examine approximately 500 sera each week for the presence of syphilitic antibodies. These tests are the Treponema pallidum haemagglutination (TPHA) test (Rathlev, 1967) and the automated reagin test (ART) using Technicon AutoAnalyzer equipment (McGrew et al., 1968) tThe sera mentioned in this column occurred early in the investigation and in common with the other sera reported here were not titrated owing to a shortage of antigen. The reactions were graded on a scheme from + to + + + inclusive. As soon as antigen became freely available all positive sera were titrated. Subsequent experience has shown that + approximates to a serum dilution of Neat -j, + + to a dilution of i-, and 3 + to a dilution of J.
On this scheme, 13 of the 16 sera were graded 1 + and the remaining three were + +. Negative results with all three screen tests were obtained in 1028 (89 %) of the sera tested and as none of the patients had any history of contact with syphilis at the time no FTA or TPI tests were done on these negative sera. One other serum was also in this group but as the patient was a contact of latent syphilis an FTA was done, giving a doubtful positive result; a subsequent TPI was negative. One other serum with positive RST and ART was a known biological false positive reactor. Table 1 shows that over half (66) of the remaining 126 sera were positive with all three screening tests; the majority of these tests were a follow-up of treatment and were expected to be positive. The next highest total (42) is again chiefly of follow-up cases, in which the TPHA test is the only positive screen test, although four of these patients had not previously had a positive test and might have been missed if the TPHA test had not been done. Column 3, Table 1 , shows 16 sera in which the ART was negative but the RST positive. These 16 results were all from patients attending the clinic. Two of the new patients had had previous courses of antibiotics for various reasons, and the other two new ones had treponemes present on dark-ground examination of lesions and were presumably of such low titre antibody that the less sensitive ART was not yet showing up as positive. Table 2 gives details of three of the previously positive ART cases, in which follow-up titrations had given a steadily falling ART titre which had become negative before the RST was done; comparative titrations undertaken when more antigen was obtained later (the results of which are shown in Table 3 ) make the RST two-to four-fold more Correlation between VDRL tests done by the ART or RST methods is to be expected, and our results confirm this. The bias in favour of the RST is partly due to the variation in titre as the finely divided weak positive results of the ART tend to be invisible in the paper-strip. (This has been evident for some years when we have compared the results of urgently requested tests, done by hand on glass slides while the patient waited, with the repeat titration done the next day by ART.) The RST was positive in 16 patients in whom the ART was negative, as shown in Table 1 , column 3, and if the RST had not been used 16 more samples would have been (wrongly) added to the total of 1028 already found to be negative. The finely divided RST antigen undoubtedly makes the results of weak positive tests easier to read than the ART tests using some commercially available carbon type VDRL antigens, and there is also a saving in time. Against this must be set the greater risk of technical error involved in individual testing of sera where large numbers are concerned although many of these mistakes can be eliminated by titrating all positive reacting sera.
It must also be pointed out that if the TPHA had not been in use 42 more samples would have been (wrongly) added to the total of 1028 found negative with ART and RST as screen tests, or the total of 1044 found negative if the RST had not been used instead of the ART.
Conclusions
It appears that the use of the TPHA together with the RST as screen tests would be a good sensitive combination to use at this time, taking convenience and expense into consideration. 
